ORIENT BIO Inc. (002630.KS) KSC

Currency In KRW

AD

Valuation

Market Cap68.53B
Enterprise Value64.64B
P/E Ratio20.88
PEG Ratio0.08
Price/Sales Ratio1.68
Price/Book Ratio0.67
Enterprise/Revenue1.34
Enterprise/EBITDA7.14

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.03

Income Statement

Revenue29.75B
Revenue/Share966.94
Gross Profit3.96B
EBITDA-2.24B
Net Income-4.57B
Diluted EPS-154.06

Balance Sheet

Total Cash38.08B
Total Cash/Share1,284.47
Total Debt1.19B
Total Debt/Equity0.02
Current Ratio14.09
Book Value Per Share2,437.8

Price History

52-Week Change-28.85
52-Week High3,264
52-Week Low1,490
Moving Average 50 Days1,867.92
Moving Average 200 Days2,065.06

Statistics

Average Volume151,498
Shares Outstanding29.65M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:2
Last Split DateSeptember 22, 2026
AD